共 41 条
[1]
Kremer Hovinga JA,(2008)Current management of thrombotic thrombocytopenic purpura Curr Opin Hematol 15 445-50
[2]
Meyer SC(2008)Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura Blood 112 11-8
[3]
Sadler JE(2002)Rituximab therapy for refractory thrombotic thrombocytopenic purpura Blood Cells Mol Dis 28 385-91
[4]
Gutterman LA(2002)Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab Am J Hematol 71 105-8
[5]
Kloster B(2005)Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura Int J Hematol 81 433-6
[6]
Tsai HM(2007)Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature Swiss Med Wkly 137 518-4
[7]
Chemnitz J(2008)Rituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literature J Clin Apher 23 151-6
[8]
Draube A(2007)Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13 Br J Haematol 136 451-61
[9]
Scheid C(2007)Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura Expert Opin Pharmacother 8 437-44
[10]
Staib P(undefined)undefined undefined undefined undefined-undefined